INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
99.03 USD
+1.82 (+1.87%)
98.9 USD
-0.13 (-0.13%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 407.9M 74.76% | 624.799M 53.17% | 802.804M 28.49% | 923.25M 15.00% | 1.027B 11.24% | 1.152B 12.17% | 1.282B 11.28% | 1.411B 10.06% | 1.584B 12.26% | 1.567B -1.07% | 1.56B -0.45% | |
| EBITDA YoY % growth | -45.74M -18.25% | -37.425M 18.18% | 42.633M 213.92% | 180.52M 323.43% | 216.35M 19.85% | 268.01M 23.88% | 331.4M 23.65% | 376.84M 13.71% | 452.17M 19.99% | 461.75M 2.12% | N/A | |
| EBIT YoY % growth | -47.6M -19.30% | -40.271M 15.40% | 36.083M 189.60% | 27.394M -24.08% | 52.693M 92.35% | 86.151M 63.50% | 121.71M 41.28% | 167.79M 37.86% | 223.52M 33.21% | 308.35M 37.95% | 460.02M 49.19% | |
| Operating Margin | -11.67% | -6.45% | 4.49% | 2.97% | 5.13% | 7.48% | 9.49% | 11.89% | 14.11% | 19.68% | 29.49% | |
| EPS YoY % growth | -1.64 -5.81% | -0.74 54.88% | 1.73 333.78% | 1.06 -38.85% | 1.77 67.66% | 2.64 48.82% | 3.50 32.78% | 4.55 29.90% | 6.07 33.31% | 5.06 -16.64% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.68 -41.17% | 0.09 -8.52% | 0.38 -14.89% | 0.45 31.27% | 0.80 18.37% | 0.35 279.08% | 0.42 9.19% | 0.48 7.41% | 0.58 -28.03% |
| Revenue Q2Q % growth | 267.98M 11.79% | 218.79M 8.68% | 247.6M 14.06% | 254.58M 13.40% | 300.19M 12.02% | 263.32M 20.35% | 279.69M 12.96% | 288.43M 13.30% | 318.81M 6.20% |
| EBITDA Q2Q % growth | 57.776M 50.33% | 31.649M 1,930.08% | 55.546M 1,667.85% | 52.978M 167.85% | 70.914M 22.74% | 52.02M 64.37% | 52.02M -6.35% | 53.04M 0.12% | 53.04M -25.21% |
| EBIT Q2Q % growth | 19.797M -37.91% | -5.139M -246.09% | 9.596M 389.38% | 13.419M 39.14% | 31.965M 61.46% | 10.547M 305.22% | 13.841M 44.24% | 16.55M 23.33% | 20.864M -34.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.34 -43.33% | -0.20 | 0.54 | 271.72% |
| Q2 2025 Q2Q % growth | 0.45 40.63% | 0.21 | 0.24 | 114.53% |
| Q1 2025 Q2Q % growth | 0.10 129.41% | -0.25 | 0.35 | 139.49% |
| Q4 2024 Q2Q % growth | 1.15 134.69% | 0.75 | 0.40 | 54.07% |
| Q3 2024 Q2Q % growth | 0.60 306.90% | 0.08 | 0.52 | 681.29% |
| Q2 2024 Q2Q % growth | 0.32 178.05% | -0.14 | 0.46 | 325.04% |
| Q1 2024 Q2Q % growth | -0.34 35.85% | -0.66 | 0.32 | 48.86% |
| Q4 2023 Q2Q % growth | 0.49 390.00% | -0.09 | 0.58 | 642.33% |
| Q3 2023 Q2Q % growth | -0.29 51.67% | -0.59 | 0.30 | 51.01% |
| Q2 2023 Q2Q % growth | -0.41 22.64% | -0.58 | 0.17 | 29.39% |
| Q1 2023 Q2Q % growth | -0.53 13.11% | -0.67 | 0.14 | 21.27% |
| Q4 2022 Q2Q % growth | 0.10 211.11% | -0.58 | 0.68 | 117.32% |
| Q3 2022 Q2Q % growth | -0.60 -57.89% | -0.78 | 0.18 | 23.21% |
| Q2 2022 Q2Q % growth | -0.53 -10.42% | -0.63 | 0.10 | 15.95% |
| Q1 2022 Q2Q % growth | -0.61 -1.67% | -0.81 | 0.20 | 24.87% |
| Q4 2021 Q2Q % growth | -0.09 67.86% | -0.45 | 0.36 | 79.81% |
| Q3 2021 Q2Q % growth | -0.38 2.56% | -0.63 | 0.25 | 39.38% |
| Q2 2021 Q2Q % growth | -0.48 45.45% | -0.65 | 0.17 | 26.57% |
| Q1 2021 Q2Q % growth | -0.60 10.45% | -0.67 | 0.07 | 10.87% |
| Q4 2020 Q2Q % growth | -0.28 | -0.49 | 0.21 | 43.08% |
| Q3 2020 Q2Q % growth | -0.39 | -0.74 | 0.35 | 47.01% |
| Q2 2020 Q2Q % growth | -0.88 | -1.12 | 0.24 | 21.57% |
| Q1 2020 Q2Q % growth | -0.67 | -0.58 | -0.09 | -15.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 224.501M 10.49% | 224.88M | -379K | -0.17% |
| Q2 2025 Q2Q % growth | 217.086M 10.82% | 218.59M | -1.504M | -0.69% |
| Q1 2025 Q2Q % growth | 201.317M 22.75% | 199.07M | 2.247M | 1.13% |
| Q4 2024 Q2Q % growth | 239.718M 24.52% | 241.74M | -2.022M | -0.84% |
| Q3 2024 Q2Q % growth | 203.191M 32.54% | 201.55M | 1.641M | 0.81% |
| Q2 2024 Q2Q % growth | 195.885M 29.65% | 193.25M | 2.635M | 1.36% |
| Q1 2024 Q2Q % growth | 164.01M 28.24% | 164.67M | -660K | -0.40% |
| Q4 2023 Q2Q % growth | 192.508M 39.60% | 190.98M | 1.528M | 0.80% |
| Q3 2023 Q2Q % growth | 153.302M 40.39% | 157.54M | -4.238M | -2.69% |
| Q2 2023 Q2Q % growth | 151.092M 65.31% | 139.07M | 12.022M | 8.64% |
| Q1 2023 Q2Q % growth | 127.897M 84.29% | 121.69M | 6.207M | 5.10% |
| Q4 2022 Q2Q % growth | 137.9M 75.89% | 131.85M | 6.05M | 4.59% |
| Q3 2022 Q2Q % growth | 109.2M 76.99% | 96.201M | 12.999M | 13.51% |
| Q2 2022 Q2Q % growth | 91.4M 72.45% | 79.841M | 11.559M | 14.48% |
| Q1 2022 Q2Q % growth | 69.4M 71.78% | 65.454M | 3.946M | 6.03% |
| Q4 2021 Q2Q % growth | 78.4M 70.43% | 78.117M | 283K | 0.36% |
| Q3 2021 Q2Q % growth | 61.7M 72.35% | 56.725M | 4.975M | 8.77% |
| Q2 2021 Q2Q % growth | 53M 334.43% | 44.747M | 8.253M | 18.44% |
| Q1 2021 Q2Q % growth | 40.4M 89.67% | 37.678M | 2.722M | 7.22% |
| Q4 2020 Q2Q % growth | 46M | 41.895M | 4.105M | 9.80% |
| Q3 2020 Q2Q % growth | 35.8M | 23.203M | 12.597M | 54.29% |
| Q2 2020 Q2Q % growth | 12.2M | 8.009M | 4.191M | 52.33% |
| Q1 2020 Q2Q % growth | 21.3M | 21.688M | -388K | -1.79% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.63% | -0.13% | 13.12% | 110.93% |
| Revenue | -0.01% | -0.91% | 0.03% | 0.13% |